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This year, the Albert Lasker Basic Medical Research Award will be shared by Michael Sheetz,
James Spudich, and Ronald Vale for discoveries concerning the biophysical actions of cytoskeletal
motor-protein machines that move cargo within cells, contract muscles, and enable cell motility.‘‘Nothing is more revealing than
movement.’’—Martha Graham
As the Mars rover Curiosity begins its
unmanned exploration of the surface of
the Red Planet, Earth-bound scientists
debate whether alien life can be recog-
nized as such by an automated system
performing analytical experiments based
on our own experience with the biochem-
istry of living organisms. Yet there can
be no doubt that one observation would
settle the matter forever: the observation
of something strolling by the rover’s
camera and turning to look at it. The
biochemistry of life may be moot, but
one phenomenon is linked to it so tightly
as to not be debatable: purposeful move-
ment. Not every living organism exhibits
this property in an obvious fashion, but
anything that exhibits it is living. Nor
is such movement confined to the
organism as a whole or to its append-
ages. Inside of every living cell is a vast
and complex transportation network
resembling that of 19th century England,
with cargo being hauled on railroad
tracks to precise destinations by sophis-
ticated machinery. Proper operation of
this system is essential for the function
of all eukaryotic cells, but nowhere is it
more dramatically important than in the
central nervous system, where neurons
as long as a meter depend on machines
to transport substances as small as
acetylcholine and as large as ribosomes
vast distances with precision and speed.
The 2012 Lasker Basic Medical Research
Award recognizes the three scientists
who discovered the engines that power
such machines and showed how they
work.History
The study of motility in biology has a long
history, but its molecular investigation
began in the middle of the 20th century,
when Hugh Huxley and others proposed
and later validated a model for how an
ATP-dependent motor protein, myosin,
might drive muscle contraction. A major
figure in that story was Jim Spudich,
who started his career at Stanford in
1971 by trying to obtain evidence for
Huxley’s swinging/tilting lever arm hypo-
thesis for muscle contraction, which
requires a large conformational change
in the myosin head domain during the
power stroke. Although studies of muscle
led many people to conclude that other
forms of motility might operate in similar
ways, identification of the players in
those systems eluded investigators until
the 1980s, in large part because there
was no assay that would permit their
biochemical isolation.
All that changed during a remarkable
four-year period that began in 1982,
when Mike Sheetz decided to take a
sabbatical at Stanford in the Spudich
laboratory. There, he undertook the
formidable task of developing an in vitro
motility assay that did not involve
the enormous biochemical complexity
of muscle fibers or cilia and flagella.
By coating beads with crude heavy mero-
myosin preparations, Sheetz and Spudich
were able to show in 1983 that ATP-
dependent movement along actin cables
in flayed algal cells could be observed
directly (Sheetz and Spudich, 1983); this
was followed rapidly by an improved
assay using purified myosin and actin,
which allowed them to demonstrate that
myosin can move along actin cablesCell 150, Sepwith a velocity comparable to that of
muscle contraction (Spudich et al.,
1985). Spudich and associates went on
to use this assay to establish the biophys-
ical parameters for myosin movement,
to validate the swinging/tilting lever
model in detail (e.g., Bryant et al., 2007),
and to show that cytoplasmic myosin
powers cytokinesis (reviewed in Robinson
and Spudich, 2004). His studies also
mark the beginning of the field of single
molecule biology, which has made impor-
tant contributions to our understanding
of many cellular processes, including
DNA replication.
Ron Vale enters the picture at the
same time. He met Sheetz and Spudich
in 1982, when he was a graduate student
in neuroscience in Eric Shooter’s lab
at Stanford. Working with Sheetz and
Andrew Szent-Gyorgyi, Vale used their
newly developed assay to show that
myosin movement on actin is calcium
dependent (Vale et al., 1984). Then, in
1983, he decided to employ the same
principles to develop an assay for the
transport of substances along the axons
in neurons and, accompanying Sheetz
to the Marine Biology Laboratory at
Woods Hole, began, with collaborators
Bruce Schnapp and Thomas Reese, to
carry out experiments that led to the
biochemical identification of the force-
generating molecule. In a landmark series
of five papers in 1985, Sheetz, Vale, and
coworkers published the first in vitro
assay for cytoplasmic transport and
used it to show: (1) that axonal transport
runs along railroad tracks and does not
operate via fluid flow, as others had
proposed, and that the railroad tracks
are microtubules (Vale et al., 1985b); (2)tember 14, 2012 ª2012 Elsevier Inc. 1093
Figure 1. A Kinesin Motor Protein Carries a Vesicle along a Micro-
tubule
Still image taken from ‘‘The Inner Life of the Cell’’ (http://multimedia.mcb.
harvard.edu/). Animation conception and scientific content by Alain Viel and
Robert A. Lue. Animation by John Liebler/XVIVO.that the transport along single
microtubules is bidirectional
(Schnapp et al., 1985); (3)
that a single protein, which
could be isolated from either
squid or mammalian brain
and was later dubbed kinesin,
was sufficient to power this
transport in an ATP-depen-
dent manner (Vale et al.,
1985c); (4) that kinesin-pow-
ered transport operates solely
in the plus-end direction
(toward the nerve terminal)
(Vale et al., 1985a); (5) and
that minus-end motion from
the terminal toward the cell
body requires a different
motor protein that has the
properties of the microtu-
bule-binding protein dynein
(Vale et al., 1985d). One may
assume that Vale’s Ph.D.defense, which occurred that same year,
was a relatively painless affair.
Vale went on, as an independent inves-
tigator, to develop a complete struc-
tural model for kinesin action. Together
with UCSF colleague Bob Fletterick, he
worked out the three-dimensional struc-
ture of kinesin by X-ray crystallography
and showed that it is similar to the
structure of myosin (Kull et al., 1996). He
then joined with Ron Milligan to use
electron microscopy to determine how
kinesin binds to tubulin and how its nucle-
otide-dependent conformational change
powers its movement (reviewed in Vale
and Milligan, 2000). More recently, he
has turned his attention to dynein, a
much larger motor protein about which
much less is known. He has determined
structures of its tubulin-binding domain
and its motor domain, which have begun
to shed light on how ATP hydrolysis
powers its retrograde transport function
(Carter et al., 2011).
The Field Today
With the advent of complete genome
sequencing, the general importance of
the work of Sheetz, Spudich, and Vale
has become even more evident. For ex-
ample, the kinesin superfamily in humans
encompasses 45 distinct motor proteins.
These molecules power not just axonal
transport, but also, among other things,
vesicle trafficking, messenger RNA local-1094 Cell 150, September 14, 2012 ª2012 Elization, ribosome transport for local
protein synthesis, the transport of whole
mitochondria, chromosome movement,
microtubule dynamics, and the transport
of viruses within their host cells.
Much has also been learned about the
molecules that regulate these motors. A
family of small GTPases, the Rab pro-
teins, which were initially identified in the
late 1980s, has emerged as master
regulators of intracellular trafficking pro-
cesses in eukaryotic cells. Rab proteins
cycle between distinct conformations
that are dependent on their guanine-
nucleotide-bound status: an active (GTP-
bound) state, in which they localize to the
cytosolic face of specific membranes
and recruit downstream effector pro-
teins, which include microtubule-bound
kinesin and cytoplasmic dynein motor
complexes. Other Rabs associate with
microtubule-based motors via adaptor
proteins that simultaneously interact with
both the GTP-bound Rab and specific
motor complexes. Binding to Rab pro-
teins initiates a series of intracellular traf-
ficking steps, including vesicle motility.
Figure 1 shows an artist’s conception of
a kinesin motor protein walking a large
Rab-bound vesicle along a microtubule
railroad track.
But kinesins are far from the whole
story. In the central nervous system alone,
the formation of new synapses requires
active transport driven by molecularsevier Inc.motor proteins to move syn-
aptic cargo to their specific
sites of action along both
microtubules (where the
motors are both kinesin and
dynein, depending on the
direction of motion) or actin
filaments (where the motor is
cytoplasmic myosin). These
mechanisms are crucial both
for synaptogenesis and for
activity-dependent changes
in synaptic strength during
plasticity.
Much also remains to be
learned about dynein and the
way that it is regulated. In
contrast to the relatively sim-
ple structure of kinesin, the
dynein motor proteins typi-
cally have six tandemly linked
so-called AAA+ (ATPases
associated with diverse cel-lular activities) domains arranged in a
ring, a long N-terminal tail, and a coiled-
coil stalk. Cytoplasmic dyneins function
as individual homodimers and, as noted
above, are responsible for minus-end-
oriented transport along microtubules.
But there are also axonemal dyneins,
found in flagella and cilia, that are
anchored in arrays to peripheral microtu-
bules by their N-terminal tails and
generate sliding motions of adjacent
microtubule doublets toward the plus
end. It appears that the coiled-coil stalk
transmits conformational information
between the AAA+ domains and the
microtubule-binding domain. In the dy-
nein arrays, a number of isoforms of
axonemal dyneins are integrated to
generate the bending motions of the
flagella and cilia filaments.
A crystal structure of an ‘‘ATP-bound’’
and/or ‘‘ADP-Pi-bound’’ state will be
needed to reveal the key ‘‘prestroke’’
conformation of dynein; the current struc-
tures are of the ADP (Dictyostelium) and
nucleotide-free (yeast) ‘‘post-stroke’’
states. Information on both the pre- and
post-powerstroke conformations will be
essential for understanding the motility
cycle of dynein, as it has been for myosin.
But, as Cho and Vale point out in a recent
review (Cho and Vale, 2012), there are
likely to be many more important con-
formations to investigate, as dynein has
three other nucleotide-binding sites in
addition to the main ATP hydrolysis site.
Variations in the nucleotide state of these
sites may well change the conformation
of the AAA+ ring.
The current model for dynein function
also requires more direct data to establish
precisely what conformational changes
occur during dynein’s ATPase cycle.
Structural studies of the dynein stalk will
likely provide new insight into how coiled
coils are used in biological systems.
Computational studies as well as direct
experimental observation of the con-
formational changes will be important
next steps, as will studies of the possible
role of random, diffusional motions of
the head relative to the other domains.
Of course, eventually, it will also be
necessary to work out the structure and
dynamics of the dynein holoenzyme as
it exists in the cell. Several studies have
already started to dissect how newly
discovered dynein adaptor proteins such
as Lis1 and dynactin regulate dynein’s
ATPase activity and processivity.
Also, there are important studies
ongoing concerning the myosin motor
and its mechanism, both in muscle
contraction and inside of the cell. Spudich
and coworkers have shown that the
stroke size varies with the type of myosin,
from 10 nm for myosin II to 36 nm for
myosin VI (the only myosin that moves in
the minus-end direction; for example,
Bryant et al., 2007). The force generated
by a single myosin molecule is impres-
sive: 5 pN or more. Some myosins have
a lever arm swing of about 70 degrees,
but others, despite having a short canon-
ical lever arm, swing through an angle of
almost 180 degrees. Some, like myosin
V and VI, are processive, whereas others,
such as myosin II, appear not to be. It
seems that, at least for myosin V, when
the lever arm stroke is completed, the
trailing head of the two-headed molecule
searches for the next actin-binding site
by free diffusion. X-ray diffraction studies,
not only of myosin itself (first by Ivan
Rayment’s lab and then by the groups of
Carolyn Cohen and Anne Houdusse), but
also of intact muscles and single muscle
fibers with permeabilized membranes
have revealed the structural changes
that underlie force generation and work
production by this motor. The general
structural features of the motor domain
are now well established, as is a subsetof the structural changes that occur
during the actin-myosin catalytic cycle
(reviewed in Sweeney and Houdusse,
2010). Not yet visualized are the structural
rearrangements triggered by actin
binding and the way that they are coupled
to force generation and product release.
Time-resolved low-angle X-ray diffraction
on contracting muscle fibers using syn-
chrotron radiation sources has also
been used recently (by Hugh Huxley and
others; see Huxley, 2004) to follow
movement of myosin heads with both
temporal and spatial resolution under
near physiological conditions.
Motor proteins have also been shown
to play important roles in human disease.
Mutations in kinesins cause inherited
neuropathies such as Charcot-Marie
Tooth disease, as well as some kidney
diseases, and mutations in myosin or its
binding proteins often lead to severe
myopathies, including familial hyper-
trophic cardiomyopathy, an autosomal
dominant disorder that can cause sudden
death in young athletes. Dynein defi-
ciencies give rise to chronic infections of
the respiratory tract due to cilia dysfunc-
tion. Drugs that target kinesin are under
development for cancer chemotherapy,
and myosin-targeting drugs are being
tested in the clinic for heart disease.
Final Thoughts
There are a number of morals from this
story, not the least of which is the impor-
tance of a good biochemical assay. The
power of fluorescent-labeling and multi-
photon microscopy has tended to shift
the emphasis in cell biology away from
in vitro biochemical studies toward direct
observation in living cells. Though this is
clearly valuable, it is good to remember
how much progress can be made in un-
raveling the details of a complex system
if it can be replicated in such a way that
its parts can be identified and their
functions studied in relative isolation.
The 2012 Lasker Award to Michael
Sheetz, James Spudich, and Ronald
Vale is a testimony to what can be learned
by developing the right assay and follow-
ing where it leads.
Galileo Galilei, after being forced to
recant his belief that the Earth moves
around the sun, is said to have mut-
tered ‘‘Eppur si muove’’—‘‘And yet, it
moves’’ —as he was led away to houseCell 150, Separrest. It was Galileo, of course, who first
used a telescope to observe the Red
Planet and later made precise measure-
ments of the changes in the distance of
Mars from the Earth to support his claim
that the planets revolve around a fixed
point that is not the Earth. Curiosity will
probably not be fortunate enough to
observe a Martian moving past its
camera lens, but if we were able to
look inside even the most primitive
unicellular extraterrestrial organism, the
odds are we would see that ‘‘and yet,
it moves.’’ Moreover, that movement
would be not just the Brownian motion
of individual particles but, rather, pur-
poseful movement along specific tracks
to specific destinations. And behind the
movement will be motors. Sheetz,
Spudich, and Vale opened the door to a
more detailed understanding of how the
motors that power such movement in
earthly cells perform this remarkable
and essential job.
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